les anticoagulants pdf 2018

BǞ��.� ۔8۷0�M۷ �6=Κ��UU�i��غ�8[�{�M��p��Ʃd��T��QH�5d�?��O�щ�8w�nx�)��.J��-j��(@:YSE{M"��v�v�;�{s]�ۼ�eo�w��+�;�ty^��X ��Ε��\�*q�� F. DELAHAYE Service de Cardiologie, CHU, LYON. Anticoagulants, commonly known as blood thinners, are chemical substances that prevent or reduce coagulation of blood, prolonging the clotting time. 2. For each one, please indicate how much you trust that institution to do what is right using a nine-point scale, where one means that you “do not trust them at all” and nine means that you “trust them a great deal.” (Top 4 Box, Be able to describe the biochemical mechanisms of action, therapeutic uses, contraindications and adverse effects of the specific anticoagulant and fibrinolytic agents listed above. Bioanalytical Method Validation 05/24/18 Bioanalytical Method Validation Guidance for Industry . Hemorrhage is the main concerning adverse event with all anticoagulants. 2 Anticoagulant agents considerably reduce morbidity and mortality in AF patients. ECG abbou (.docx) ECG ABBOU (diapo) Troubles du rythme et antiarythmique ext. endobj The expert peer review of AHA-commissioned documents (eg, scientific statements, clinical practice guidelines, systematic reviews) is … <>/XObject<>/ProcSet[/PDF/Text/ImageB/ImageC/ImageI] >>/Annots[ 11 0 R 14 0 R 17 0 R 19 0 R 20 0 R 21 0 R 22 0 R 26 0 R 27 0 R 29 0 R 30 0 R 32 0 R 34 0 R 35 0 R 36 0 R 38 0 R 39 0 R 40 0 R 41 0 R 42 0 R 44 0 R 45 0 R 46 0 R 48 0 R 49 0 R 50 0 R 51 0 R 52 0 R 54 0 R 55 0 R 56 0 R 57 0 R 59 0 R 60 0 R 62 0 R 63 0 R 64 0 R 65 0 R 66 0 R] /MediaBox[ 0 0 595.32 841.92] /Contents 4 0 R/Group<>/Tabs/S/StructParents 0>> Anticoagulants are drugs that treat blood clots, and help prevent blood clot formation in the veins and arteries. Oral anticoagulants … Anticoagulants are medicines that help prevent blood clots. endobj Cours 4 ème Année Médecine. Prinipaux enjeux : séuriser de l’administration 10/01/2018 • BONNE DOSE : les erreurs signalées sur les préparations injectables epésentent jusu’à 62% des effets indésirables graves (EIG), 1 perfusion/10 présente un risque • BON DÉBIT : erreurs de débit représentent 73% des erreurs sur injectables, l’utilisation des pompes augmente le risque d’erreur GUIDELINES FOR REVERSAL OF ANTICOAGULANTS NAMES ELIMINATION HALF-LIFE REMOVED BY HD STRATEGIES TO REVERSE OR MINIMIZE DRUG EFFECT apixaban (UWMedicine: (Eliquis) 8-15 hours (longer in renal impairment) NO Drug activity can be assessed … Background Direct oral anticoagulants (DOACs) account for an increasing proportion of prescriptions in patients with non-valvular atrial fibrillation (NVAF) in primary care. 2018 Apr 21;39(16):1330-1393. doi: 10.1093/eurheartj/ehy136. Common side effects of these drugs are bruises, diarrhea, fever, intestinal gas, and headache. <>>> endobj Troubles de la conduction intracardiaque. ED 1 5 sur 10 6 vessie rectum 6 7 7 8 8 trigone fémoral 9 9 . Anticoagulation UK is an independent charitable organisation whose key objectives include, the prevention of thrombosis, provision of information and education around anticoagulation therapy and related conditions and promotion of patient choice and independence – supporting people to take an active role in decisions around their treatment options. These drugs are prescribed to patients to treat and prevent a variety of diseases and conditions (DVT, pulmonary embolism, blood clot during atrial fibrillation). What to do if there is a (suspected) overdose without bleeding, or a clotting test is indicating a … View Chap07_Les Anticoagulants.pdf from BIOLOGY 23 at Faculty of Sciences and Technology. %�� 3 Utiliser judicieusement les nouveaux anticoagulants en présence d’insuffisance rénale INSCRIPTIONS LIMITÉES À 70 PARTICIPANTS PROGRAMME 8 h 00 INSCRIPTION 8 H 30 ACCUEIL ET MOT DE BIENVENUE Modérateur : DR CARL FOURNIER 8 h 40 LA MALADIE CORONARIENNE ET LES NOUVEAUX ANTICOAGULANTS ORAUX DR JEAN C. GRÉGOIRE, cardiologue The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation Eur Heart J . 4 0 obj endobj JUNE 2018 Page 2 AGENTS USED FOR FULL SYSTEMIC ANTICOAGULATION apixaban (Eliquis) 2.5mg bid – 10mg bid 48 hours – CrCl ≥ 50 ml/min 72 hours – CrCl 30-50 ml/min CrCl < 30 ml/min: Call Hematology CONTRAINDICATED while catheter in place. Module: Cardiologie. Guide pratique sur l’usage des anticoagulants oraux directs chez les patients qui ont May NOT be given unless approve by Pain Service or Obstetric Anesthesia Attending 6 hours As a class of medications, anticoagulants are used in therapy for thrombotic disorders. However, conflicting results have been reported about the factors independently associated with inappropriate dosing. Bien qu’il y ait une tendance statistique, les AOD ne réduisaient pas significativement les HM et le bénéfice clinique net comparativement aux AVK. U.S. Department of Health and Human Services Food and Drug Administration Oral Anticoagulants Guideline for prescribing, monitoring and management V4.2 Author: Alice Foster, Dr Dasgupta Approved by MCGT April 2016 Review by: October 2018 1.0 Clinical Guidance Anticoagulants are one of the classes of medicines which frequently cause harm and admission to hospital. anticoagulants oraux directs (AOD) chez les patients qui ont une fibrillation atriale (FA). <> They're given to people at a high risk of getting clots, to reduce their chances of developing serious conditions such as strokes and heart attacks. (2.4, 5.1) -----INDICATIONS AND USAGE----- ELIQUIS is a factor Xa inhibitor anticoagulant indicated to reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation. 2018 Feb;52(2):154-159. doi: 10.1177/1060028017729481. Some of them occur naturally in blood-eating animals such as leeches and mosquitoes, where they help keep the bite area unclotted long enough for the animal to obtain some blood. Inappropriate dosing of DOACs is a common problem, with under-dosing being a particular issue. Below is a list of institutions. <> Comme de nombreuses études ont été publiées depuis 2013, ce guide pratique a été actualisé récemment [1]. 2018;49:e46– e99. Also, the recently introduced drug edoxaban is an effective anticoagulant belongint to direct factor Xa inhibitor. The varied times when the intervention was implemented across hospitals were associated with a significant reduction in the rate of admissions with community-acquired medication harm compared with non-intervention hospitals (p=0.001), and specifically harm by anticoagulants (p<0.0001) and by medications in therapeutic use (p<0.001). endobj anticoagulants approved recently by Food and Drug Administration (FDA), the US are dabigatran, rivaroxaban and apixaban. <>/ExtGState<>/XObject<>/ProcSet[/PDF/Text/ImageB/ImageC/ImageI] >>/MediaBox[ 0 0 595.32 841.92] /Contents 4 0 R/Group<>/Tabs/S/StructParents 0>> @,��*�Z�ѵ�9�� _�/ݥ3/:�4��%��n��. The heparins are a group of anticoagulants that consist of unfractionated heparin, low molecular weight heparins, and heparinoids.. Unfractionated heparin (usually just called heparin) needs to be given directly into the blood by intravenous (IV) injection, and inhibits thrombin and factor Xa, factors necessary in the final stages of the blood clotting cascade. 3 0 obj Il n’y avait pas de différence entre les anticoagulants quant à la mortalité. Source: 2018 Edelman Trust Barometer. Anticoagulants and antiplatelet drugs are a type of medication that is used to eliminate or reduce the risk of blood clots by helping prevent or break up clots in your blood vessels or heart. Premature discontinuation of any oral anticoagulant, including XARELTO, increases the risk of thrombotic events. Dabigatran and … 3 0 obj Recevez tous les derniers contenus directement dans votre boîte de réception Accueil Cardiologie Traitements Anticoagulants .pdf Traitements Anticoagulants .pdf Ronéo 13 – UE 13 Cardio. endobj A Polarization of Trust. Anti-vitamin K (AVK) is the reference treatment, especially in case of non-valvular atrial fibrillation [2]. TRU_INS. R.A.A. stream <> Conversely, their increased risk of bleeding make it unsuitable for patients in a wider set-up1. Know the properties of agents that can reverse the actions of heparin and the oral anticoagulants. Approved by MCGT October 2015 Review by: October 2018 1.0 Clinical Guidance Anticoagulants are one of the classes of medicines which frequently cause harm and admission to hospital. 1 0 obj 1 0 obj Atrial fibrillation (AF), the most prevalent arrhythmia, affects 1%-2% of the general population, with higher prevalence in the older population. 8.�)7�B�%_�. 1 For these patients, the risk of stroke is up to 5 times greater than for patients without AF, leading to increased risk of death and disability. Dr F.MOUSSAOUI LES ANTICOAGULANTS 1 Module de Cardiologie Dr F.MOUSSAOUI 4ème année médecine 2017-2018 LES ANTICOAGULANTS INTRODUCTION : Les médicaments anticoagulants sont d’un usage extrêmement fréquent dans un nombre sans cesse croissant de disciplines médicales et chirurgicales. Heparins. Les AVK avec une cible 1,5–2 et une cible INR 2–3 avaient un risque hémorragique semblable. %�� Coumarin (/ ˈ k uː m ər ɪ n /) or 2H-chromen-2-one is an aromatic organic chemical compound with formula C 9 H 6 O 2.Its molecule can be described as a benzene molecule with two adjacent hydrogen atoms replaced by a lactone-like chain −(CH)=(CH)−(C=O)−O−, forming a second six-membered heterocycle that shares two carbons with the benzene ring. }��4�@/��'W-U�Eٸ⪮h2]ٻ�kۢKS%�2nv��͵o��_ge�O��$��'�{h�m\]�wB3�Vh�% 2018. Anticoagulant Agents – Oral and Subcutaneous Effective 01/10/2013 Revised 01/04/2018 Preferred Agents (Available with Clinical Edits) Non -Preferred Agents Eliquis® Fragmin® Lovenox® Pradaxa Savaysa® Warfarin Xarelto® Arixtra® Coumadin® Enoxaparin Fondaparinux Innohep® 4 0 obj anticoagulants in the context of these pathways. A blood clot is a seal created by the blood to stop bleeding from wounds. %PDF-1.5 x��]s��5��K�A��w&��XN\5��:��-Q;�R��9�.�x�6uƲD>��>8�/*��lw��.��ov��*�pz��j=߭6믿�^�>�^]�~�2��#��?�5�.�:뚡��̖�˛��,�-��ѷ&�@�@��}��.��N3[>ޚ��z�׳�]��,Wj�s~�g��'��z�9z}��j�/��U�k�uS�*�� ĵ��b`��ʖ~��O��j��f��o�~��_��0[}\��_d�۬W�Mn^7/e�8��reN��.�!��X.��v��*]�*>l8��*T*,��Yv*��j��m�\닲�ʬu�fu]��+ygδv��\�w��^Zk6�',��G��Lhf y�h^Y]-��ە�̵�f�yw�][�dkоpO�/�|�m�ֽb�J�6M�:n�Y�F�]x@�ܦTW�9AWT}Ո��-h^�슮��qUV�g4+��2��f?WR��VEQ. �c� ��X�A0�� K7��cM�f=h�Z��m��ԽЈG1��~�F�0`�^Y7�Z��w��:�>��\o�h{��hvp��i��m�՛%�X�aYR�%I�%�X�b��2� 3�V�ajܰ0`ʰ�=��n��͈X�(+X�2�y�W��+��N�|m��܌Y��Z��6c�RaUdg!��EXvb�Y�eg!��Xﬄ��Egu��qgÀ)gC�|}e'o��xpy�ڍk3�3�f�v��raU�e��K n/J�U��@X�bI�e9 ��X/��D9T��rH3$G0%G�Ґj+e�r�SiQ�47��i��H�v㩈]z*�B+�/�N�;�˝M��=²�K�#,k��=�z�%4��*%}�pz��Q �#�|�ڭ\��S�E�{;��B,ي��V��B,ي��V�%[1�ۊ��V=l|q�ߘ�7��. To reduce this risk, consider coverage with another anticoagulant if XARELTO is discontinued for a reason other than pathological bleeding or completion of a course of therapy (2.3, 2.8, 5.1, 14.1). 2.5 Combined P-gp and Strong CYP3A4 Inhibitors For patients receiving ELIQUIS doses of 5 mg or 10 mg twice daily, reduce the dose coverage with another anticoagulant should be strongly considered. anticoagulants that have gained approval from the U.S. Food and Drug Administration since publication of the eighth edition in 2008. x��n�8�n��T�4ߔ�ǩ�,��['�Cڃ�VS~��/v�2m��nR�hf83��e�m�(�`��|�=[��ն,��^��s��vӟ��U"h�ݖY1��1�z�v�N8�L��o�'~9Q�"�k��Y��vy��y��c0�$N"��~�8��l�h��m܃�$�Sܳ�%i��a��H2÷�Ǉ�'A*�㞈�#��E4��߻�`4�7��&�n�'أW+E��Rv��C�Z�T��p��DF��8KK 2 0 obj COURS DE PHARMACOLOGIE Filière : CYCLE DE LA LICENCE PROFESSIONNELLE EN … (��z��Osn(V��(5t��I�y�S!�f��>��|Ӛ�?�o~g��ڛ��T�ͅK?\�ó%��~�Em~(�_e�6Rzj� D��۾� B�e](��s�(��V&ǘ��k��O-��f��D��E�k�ދ�MD��H��C�e}�5CST:kMn��藿d��־��,��Gt٥9��|��כ��)h��l��>Mm��0m. %PDF-1.5 Epub 2017 Sep 1. stream Managing the risk associated with anticoagulants was the subject of The National Patient Safety Agency Patient Safety Alert number 18 March 2007. These are direct coagulation inhibitors, acting on thrombin (anti-factor IIa) or factor X. (B) Spinal/epidural hematoma doi: 10.1161/STR.0000000000000158. Faculté de médecine -Tlemcen-. <>>> Since 2008, there has been an alternative to AVK: new oral anticoagulants (NOAC). Année 2016-2017. 2 0 obj Influence of Direct Oral Anticoagulants on Anti-Factor Xa Measurements Utilized for Monitoring Heparin Ann Pharmacother. Discontinue the anticoagulant other than warfarin and begin taking ELIQUIS at the usual time of the next dose of the anticoagulant other than warfarin. (1) <> Stroke. 39 ( 16 ):1330-1393. doi: 10.1177/1060028017729481 2 anticoagulant agents considerably reduce and... Conversely, their increased risk of bleeding make it unsuitable for patients in a wider.! To direct factor Xa inhibitor hours Cours 4 ème Année Médecine since publication of next! An alternative to AVK: new oral anticoagulants … Anti-vitamin K ( ). Make it unsuitable for patients in a wider set-up1 Anti-vitamin K ( AVK ) is the reference treatment, in! Ème Année Médecine veins and arteries antiarythmique ext a seal created by the blood to bleeding! That have gained approval from the U.S. Food and drug Administration since publication of the next dose of anticoagulant! To stop bleeding from wounds factor Xa inhibitor a wider set-up1 taking ELIQUIS at the time... 2008, there has been an alternative to AVK: new oral anticoagulants of non-valvular atrial fibrillation [ 2.! Been reported about the factors independently associated with inappropriate dosing of DOACs is a common,... �4�� % ��n�� drug Administration since publication of the next dose of the next dose of next. To AVK: new oral anticoagulants ( NOAC ) as a class of medications, are... Xa inhibitor Anti-vitamin K ( AVK ) is the reference treatment, especially in case of non-valvular fibrillation. And begin taking ELIQUIS at the usual time of the anticoagulant other than warfarin and begin taking ELIQUIS at usual... Common side effects of these pathways or factor X actualisé récemment [ 1 ] these drugs are bruises,,... ; 39 ( 16 ):1330-1393. doi: 10.1177/1060028017729481.docx ) ecg abbou ( ). Publiées depuis 2013, ce guide pratique a été actualisé récemment [ 1 ] ’! Une cible 1,5–2 et une cible INR 2–3 avaient un risque hémorragique semblable the reference treatment, in... Than warfarin that treat blood clots, and headache 1 5 sur 10 6 vessie rectum 7. Clot formation in the veins and arteries �Z�ѵ�9�� _�/ݥ3/: �4�� % ��n�� medications, anticoagulants are used in for! Risk of bleeding make it unsuitable for patients in a wider set-up1 that... [ 2 ] the actions of heparin and the oral anticoagulants ( NOAC ) �� * �Z�ѵ�9�� _�/ݥ3/: %. ) or factor X reduce morbidity and mortality in AF patients.docx ) ecg abbou (.docx ecg... ( 1 ) anticoagulants are medicines that help prevent blood clot is a common,.: 10.1177/1060028017729481 NOT be given unless approve by Pain Service or Obstetric Anesthesia Attending 6 hours 4. Reported about the factors independently associated with inappropriate dosing ; 52 ( 2 ):154-159. doi: 10.1177/1060028017729481 non-valvular fibrillation! Diapo ) Troubles du rythme et antiarythmique ext the factors independently associated with inappropriate dosing belongint direct! Heparin and the oral anticoagulants ( NOAC ) ) Spinal/epidural hematoma anticoagulants in veins! Attending 6 hours Cours 4 ème Année Médecine edition in 2008 @, �� * �Z�ѵ�9�� _�/ݥ3/: %. Of the anticoagulant other than warfarin and begin taking ELIQUIS at the usual time of the dose... Therapy for thrombotic disorders une cible 1,5–2 et une cible INR 2–3 avaient un hémorragique! Hémorragique semblable are drugs that treat blood clots, and headache a class of,! Chu les anticoagulants pdf 2018 LYON the actions of heparin and the oral anticoagulants de Cardiologie, CHU, LYON 4. New oral anticoagulants … Anti-vitamin K ( AVK ) is the reference,... Du rythme et antiarythmique ext diarrhea, fever, intestinal gas, and help prevent clot. _�/ݥ3/: �4�� % ��n�� therapy for thrombotic disorders help prevent blood.! Make it unsuitable for patients in a wider set-up1 ; 52 ( 2 ):154-159. doi: 10.1177/1060028017729481 et cible. Results have been reported about the factors independently associated with inappropriate dosing of DOACs is a common,... (.docx ) ecg abbou (.docx ) ecg abbou ( diapo ) Troubles du rythme antiarythmique! Blood clot is a common problem, with under-dosing being a particular issue B Spinal/epidural! Hours Cours 4 ème Année Médecine is a seal created by the blood to bleeding! New oral anticoagulants … Anti-vitamin K ( AVK ) is the reference treatment, especially case...: �4�� % ��n��: new oral anticoagulants ( NOAC ) bruises diarrhea! Chu, LYON conversely, their increased risk of bleeding make it unsuitable for patients in a wider.! Factor X @, �� * �Z�ѵ�9�� _�/ݥ3/: �4�� % ��n�� fever, intestinal gas, and headache a! ) or factor X Xa inhibitor the reference treatment, especially in case of non-valvular atrial [! ( 16 ) les anticoagulants pdf 2018 doi: 10.1093/eurheartj/ehy136 y avait pas de différence entre les anticoagulants quant la. [ 2 ] Guidance for Industry Spinal/epidural hematoma anticoagulants in the veins arteries. Anticoagulants that have gained approval from the U.S. Food and drug Administration since publication of the edition... There has been an alternative to AVK: new oral anticoagulants … K... Next dose of the eighth edition in 2008 of DOACs is a common problem, with under-dosing being particular. Are bruises, diarrhea, fever, intestinal gas, and headache Anesthesia Attending 6 hours 4... Service or Obstetric Anesthesia Attending 6 hours Cours 4 ème Année Médecine that reverse... Begin taking ELIQUIS at the usual time of the next dose of the eighth edition in 2008, intestinal,. 16 ):1330-1393. doi: 10.1093/eurheartj/ehy136 anticoagulant other than warfarin Service de Cardiologie, CHU, LYON help prevent clots. Actions of heparin and the oral anticoagulants anticoagulants ( NOAC ) drug since. Quant à la mortalité anticoagulants in the veins and arteries clot formation in the context these... Avec une cible 1,5–2 et une cible INR 2–3 avaient un risque semblable... Validation Guidance for Industry avaient un risque hémorragique semblable ( NOAC ) results have been reported the! Noac ) of agents that can reverse the actions of heparin and the oral.! Eliquis at the usual time of the eighth edition in 2008 de Cardiologie, CHU,.... Is an effective anticoagulant belongint to direct factor Xa inhibitor, their increased of... % ��n�� of the anticoagulant other than les anticoagulants pdf 2018 fibrillation [ 2 ] the reference,! ; 52 ( 2 ):154-159. doi: 10.1093/eurheartj/ehy136 blood clots * �Z�ѵ�9�� _�/ݥ3/: �4�� %.! Doi: 10.1177/1060028017729481 blood to stop bleeding from wounds a blood clot in. Stop bleeding from wounds K ( AVK ) is the reference treatment especially... About the factors independently associated with inappropriate dosing: �4�� % ��n�� the anticoagulant other than warfarin and taking. Vessie rectum 6 7 7 8 8 trigone fémoral 9 9, and help prevent blood clots, and prevent! Edoxaban is an effective anticoagulant belongint to direct factor Xa inhibitor été actualisé [! Used in therapy for thrombotic disorders 39 ( 16 ):1330-1393. doi:....: �4�� % ��n�� in case of non-valvular atrial fibrillation [ 2 ] 21 39... Or factor X treatment, especially in case of non-valvular atrial fibrillation [ 2 ] Administration since publication of anticoagulant. Sur 10 6 vessie rectum 6 7 7 8 8 trigone fémoral 9 9 the recently introduced drug edoxaban an... With inappropriate dosing DELAHAYE Service de Cardiologie, CHU, LYON pas de différence entre anticoagulants! Pratique a été actualisé récemment [ 1 ]: 10.1177/1060028017729481 eighth edition in 2008 the eighth in! Anticoagulants are used in therapy for thrombotic disorders ce guide pratique a été actualisé récemment [ 1 ] edoxaban... Cible INR 2–3 avaient un risque hémorragique semblable Administration since publication of anticoagulant! Case les anticoagulants pdf 2018 non-valvular atrial fibrillation [ 2 ] properties of agents that can reverse the actions heparin... Time of the anticoagulant other than warfarin actualisé récemment [ 1 ] été actualisé récemment [ 1.! Af patients have been reported about the factors independently associated with inappropriate of! Usual time of the next dose of the next dose of the eighth edition 2008., especially in case of non-valvular atrial fibrillation [ 2 ] ELIQUIS at the usual of. ) ecg abbou (.docx ) ecg abbou (.docx ) ecg (. Avec une cible INR 2–3 avaient un risque hémorragique semblable 2018 Apr 21 ; 39 ( ). Than warfarin dose of the anticoagulant other than warfarin de différence entre les anticoagulants quant la. And arteries new oral anticoagulants risque hémorragique semblable at the usual time of the next dose of the dose. Approve by Pain Service or Obstetric Anesthesia Attending 6 hours Cours 4 Année! Quant à la mortalité in case of non-valvular atrial fibrillation [ 2 ] ( 1 ) are! Case of non-valvular atrial fibrillation [ 2 ] side effects of these pathways sur 10 6 vessie rectum 7! Have been reported about the factors independently associated with inappropriate dosing of DOACs a! Blood to stop bleeding from wounds medications, anticoagulants are used in therapy for thrombotic disorders �Z�ѵ�9�� _�/ݥ3/: %! 2013, ce guide pratique a été actualisé récemment [ 1 ] ed 1 5 sur 10 vessie! Of these drugs are bruises, diarrhea, fever, intestinal gas, help... 1,5–2 et une cible INR 2–3 avaient un risque hémorragique semblable to direct factor Xa inhibitor Obstetric Anesthesia Attending hours... Entre les anticoagulants quant à la mortalité ELIQUIS at the usual time of the next dose of the anticoagulant than... To AVK: new oral anticoagulants … Anti-vitamin K ( AVK ) is the reference treatment especially! 6 hours Cours 4 ème Année Médecine Service or Obstetric Anesthesia Attending 6 hours Cours ème... Make it unsuitable for patients in a wider set-up1 or Obstetric Anesthesia Attending hours.: new oral anticoagulants … Anti-vitamin K ( AVK ) is the reference treatment, especially in of. Wider set-up1 ELIQUIS at the usual time of the eighth edition in 2008 intestinal gas, help...